收费全文 | 2910443篇 |
免费 | 221082篇 |
国内免费 | 5461篇 |
耳鼻咽喉 | 39177篇 |
儿科学 | 95835篇 |
妇产科学 | 80617篇 |
基础医学 | 413026篇 |
口腔科学 | 86362篇 |
临床医学 | 262733篇 |
内科学 | 562443篇 |
皮肤病学 | 63951篇 |
神经病学 | 230956篇 |
特种医学 | 112777篇 |
外国民族医学 | 699篇 |
外科学 | 440258篇 |
综合类 | 70574篇 |
现状与发展 | 6篇 |
一般理论 | 1028篇 |
预防医学 | 223090篇 |
眼科学 | 68638篇 |
药学 | 216841篇 |
67篇 | |
中国医学 | 6401篇 |
肿瘤学 | 161507篇 |
2018年 | 30781篇 |
2017年 | 23659篇 |
2016年 | 26157篇 |
2015年 | 29914篇 |
2014年 | 41535篇 |
2013年 | 61982篇 |
2012年 | 84968篇 |
2011年 | 89577篇 |
2010年 | 53030篇 |
2009年 | 49817篇 |
2008年 | 84180篇 |
2007年 | 89239篇 |
2006年 | 90090篇 |
2005年 | 86842篇 |
2004年 | 84666篇 |
2003年 | 80868篇 |
2002年 | 78561篇 |
2001年 | 141380篇 |
2000年 | 145439篇 |
1999年 | 121801篇 |
1998年 | 33155篇 |
1997年 | 29491篇 |
1996年 | 29384篇 |
1995年 | 28364篇 |
1994年 | 26417篇 |
1993年 | 24586篇 |
1992年 | 96487篇 |
1991年 | 93751篇 |
1990年 | 90867篇 |
1989年 | 87651篇 |
1988年 | 80745篇 |
1987年 | 79176篇 |
1986年 | 75254篇 |
1985年 | 72253篇 |
1984年 | 53563篇 |
1983年 | 46024篇 |
1982年 | 26542篇 |
1981年 | 23759篇 |
1979年 | 49623篇 |
1978年 | 34265篇 |
1977年 | 29117篇 |
1976年 | 27345篇 |
1975年 | 28902篇 |
1974年 | 35270篇 |
1973年 | 33877篇 |
1972年 | 31309篇 |
1971年 | 29375篇 |
1970年 | 27146篇 |
1969年 | 25437篇 |
1968年 | 23443篇 |
Purpose
To investigate the preoperative use of combination metformin and statin versus monotherapy on biochemical recurrence (BCR) after radical prostatectomy (RP) in diabetic men.Patients and Methods
Data of 843 diabetic men who underwent RP were stratified on the basis of preoperative use of no drug or of metformin, statin, or both. Multivariable Cox models were used to test the association between treatment and BCR. In a secondary analysis, models were stratified by race and body mass index (BMI) and further adjusted for glycated hemoglobin (HbA1c).Results
A total of 259 men (31%) received statin therapy, 94 (11%) metformin, 307 (36%) metformin + statin, and 183 (22%) neither. Five-year BCR-free survival rates were 75% in metformin only versus 75% in metformin + statin versus 60% in statin versus 68% in no drug groups (log-rank, P = .003). On multivariable analysis, preoperative statin use was associated with increased BCR risk versus men receiving neither drug (hazard ratio [HR] = 1.84; 95% confidence interval [CI], 1.28-2.64). Metformin alone (HR 0.88; 95% CI, 0.53-1.47) and metformin + statin (HR 0.88; 95% CI, 0.58-1.33) were unrelated to BCR risks. In secondary analysis, the association between statin use and higher BCR risk was similar regardless of race, but was stronger among men with BMI ≥ 30 kg/m2 (HR 3.12; 95% CI, 1.70-5.72). These results were largely unchanged after adjusting for HbA1c.Conclusion
Among diabetic men undergoing RP, preoperative statin use was associated with worse BCR risk, especially among men with a high BMI, but these associations may be mitigated by concomitant use of metformin. If validated in future findings, research is needed to understand the basis for these associations. 相似文献To determine frequencies, interlaboratory reproducibility, clinical ratings, and prognostic implications of neural antibodies in a routine laboratory setting in patients with suspected neuropsychiatric autoimmune conditions.
MethodsEarliest available samples from 10,919 patients were tested for a broad panel of neural antibodies. Sera that reacted with leucine-rich glioma-inactivated protein 1 (LGI1), contactin-associated protein-2 (CASPR2), or the voltage-gated potassium channel (VGKC) complex were retested for LGI1 and CASPR2 antibodies by another laboratory. Physicians in charge of patients with positive antibody results retrospectively reported on clinical, treatment, and outcome parameters.
ResultsPositive results were obtained for 576 patients (5.3%). Median disease duration was 6 months (interquartile range 0.6–46 months). In most patients, antibodies were detected both in CSF and serum. However, in 16 (28%) patients with N-methyl-d-aspartate receptor (NMDAR) antibodies, this diagnosis could be made only in cerebrospinal fluid (CSF). The two laboratories agreed largely on LGI1 and CASPR2 antibody diagnoses (κ = 0.95). The clinicians (413 responses, 71.7%) rated two-thirds of the antibody-positive patients as autoimmune. Antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), NMDAR (CSF or high serum titer), γ-aminobutyric acid-B receptor (GABABR), and LGI1 had ≥ 90% positive ratings, whereas antibodies against the glycine receptor, VGKC complex, or otherwise unspecified neuropil had ≤ 40% positive ratings. Of the patients with surface antibodies, 64% improved after ≥ 3 months, mostly with ≥ 1 immunotherapy intervention.
ConclusionsThis novel approach starting from routine diagnostics in a dedicated laboratory provides reliable and useful results with therapeutic implications. Counseling should consider clinical presentation, demographic features, and antibody titers of the individual patient.
相似文献